-
1 Comment
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is currently in a long term uptrend where the price is trading 21.5% above its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.4.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's total revenue sank by 0.7% to $15B since the same quarter in the previous year.
Its net income has increased by 772.4% to $256M since the same quarter in the previous year.
Finally, its free cash flow fell by 104.2% to $-153M since the same quarter in the previous year.
Based on the above factors, Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited gets an overall score of 3/5.
Exchange | HK |
---|---|
CurrencyCode | HKD |
ISIN | CNE100000387 |
Industry | Medical Distribution |
Sector | Healthcare |
Market Cap | 43B |
---|---|
PE Ratio | 9.17 |
Target Price | 18.8105 |
Dividend Yield | 7.6% |
Beta | 0.51 |
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, together with its subsidiaries, researches, develops, manufactures, and sells Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials in the People's Republic of China and internationally. The company operates through Great Southern TCM, Great Commerce, Great Health, and Other segments. It is also involved in the wholesale, retail, sale, import, and export of Western and Chinese medicines, medical instruments, pharmaceutical products, medical equipment, and healthcare products; and research and development, production, and sale of beverages, food, healthcare products, and other products; and production and sale of pre-packaged food, dairy products, etc., as well as offers herbal tea, tablets, capsules, lozenges, tortoise herb jelly, etc. In addition, the company invests in health industry, such as medical services, health management, health maintenance, elderly care, etc.; and provides leasing and commercial, health, advertising, loading offloading, and warehouse services. It operates through retail chain pharmacy stores and retail stores. The company was formerly known as Guangzhou Pharmaceutical Company Limited and changed its name to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in August 2013. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 0874.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025